How Clinilabs Fast-Tracked a First-in-Human Alzheimer’s Disease Trial
Thanks to vulnerable populations, complex biomarkers, and early-phase uncertainty, Alzheimer’s research demands precision, adaptability, and unwavering operational control — all of which Clinilabs delivered for this first-in-human Alzheimer’s disease trial.
In this infographic, see how we helped accelerate a multi-arm, multisite Phase 1 Alzheimer’s study by:
- Achieving key operational milestones early or on time
- Identifying and managing 15 top-performing AD sites across the U.S.
- Delivering top-line results just 7 days after database lock
- Supporting protocol amendments with real-time insight and collaboration
